Trepo - Selaus Tutkinto-ohjelman ja opintosuunnan mukaan

Metastatic castration resistant prostate cancer (mCRPC) accounts for 8th most deaths of all cancers annually. Many kinds of methods are used in treatment of mCRPC, none of which are shown to do more than prolong the ...